-
08.04.2021
Hepatology for Dummies
7 April, the first Academy Afternoon in the GALAXY and MicrobLiver consortia was hosted by Odense University Hospital.
-
16.03.2021
PhD defence Ditlev Nytoft Rasmussen
26 March, Ditlev Nytoft Rasmussen will defend his PhD on prognostic markers in alcohol-related liver disease.
-
11.03.2021
GALAXY online meeting
1-3 March, GALAXY hosted a 3 days online meeting for all partners together with project MicrobLiver
-
25.01.2021
Multinational collaboration establish common cut-offs for liver stiffness measurements
Finally, researchers have agreed on the interpretation of liver stiffness measurements. There has long been disagreement about which cut-off values to use for transient elastography (FibroScan). With the use of GALAXY data, a multinational collaboration has now established cut-off values to rule in and rule out compensated advanced chronic liver disease across the four major liver disease etiologies.
-
20.01.2021
Inclusion of patients concluded in the fourth GALAXY study
55 patients with alcoholic liver disease are now included in the SYN-ALD a randomized controlled trial in GALAXY.
-
04.12.2020
GALAXY part of multi-centre study published in AP&T
New study shows that digital assistance improves physician’s accuracy to predict who will develop complication to cirrhosis and die from alcohol-related liver disease.
-
03.09.2020
ILC2020
Five abstracts from the GALAXY project was presented on 27-29 August at the Digital International Liver Congress 2020
-
15.05.2020
136 ALD patients included in the Rifaximin trial
In May 2020 an important milestone in the Rifaximin study was reached, since the last of 136 participants was included.
-
23.03.2020
GALAXY Steering Committee Meeting
The GALAXY partners met in Copenhagen for Steering Committee Meeting
-
18.11.2019
Best of the Liver Meeting 2019
GALAXY had two oral presentations at the Liver Meeting 2019 - one was selected as part of Best of Liver Meeting 2019
-
09.11.2019
GALAXY Advisory Board
GALAXY hosted meeting at AASLD in Boston